Global Platinum Cancer Drugs Market Outlook, Prospect and Future 2026
Summary - A new market study, titled “Global Platinum Cancer
Drugs Market -Segment Analysis, Opportunity Assessment, Competitive
Intelligence, Industry Outlook 2018-2026” has been featured on WiseGuyReports.
Platinum-based cancer drug
Market
Interest for
platinum-based cancer drugs represented the incomes worth US$ 1.1 Bn, in 2018.
Proceeded with an inclination for the utilization of noble metals in the cancer
treatments is principally supporting the development of platinum-based cancer
drug market. ~4.5% CAGR has been anticipated for the Market market more than
2019-2029, which is conspicuously evaluated to be driven by the rapidly growing
occurrence of cancers. Asia Pacific market is the greatest and fastest-growing
region in the platinum-based cancer drug market that grows with the ~17% CAGR
through 2029.
Market Insight
Introduction of Nobel metals in cancer treatment to Open
Doors to Multiple Opportunities
The demand for the use of complex co-ordinates of the noble
metals including platinum, palladium, and others in the cancer treatment.
However, among the various drugs used in chemotherapy and other treatments,
platinum-based drugs are the most compelling ones.
The platinum-based drugs are one of the most active agents
used in cancer treatment and therapy. The numerous drugs such as cisplatin,
oxaliplatin, carboplatin, and others are the co-ordinate platinum complexes
that are mainly used in cancer treatment. Furthermore, several platinum-based
drugs are undergoing in the are undergoing clinical trials. These drugs show
high anticancer properties in a variety of tumors.
Factors driving the global Platinum-based drugs Market:
The Platinum-based drugs are the majorly used as the
chemotherapeutic agents used to treat cancer. Growing occurrence of different
types of cancer such as breast cancer, lung and bronchus cancer, colon and
rectum cancer, bladder cancer, and liver cancer has a positive impact on the
growth of the market. People with cancer require more than one type of
treatment. Further, the availability of many types of FDA approved platinum
drugs for several types of cancers are propelling the growth of the
platinum-based cancer drug market. the deaths occurred due to the cancers are
increasing. According to the National Cancer Institute, the number of new
cancer cases per year is expected to rise to 23.6 million each year.
Thus, this Increasing concerns over high death rates due to
cancer are responsible for the growth of Cancer drugs market over the forecast
period. Further, government aid and help from NGO that promotes cancer
care/treatment. The growing awareness about the platinum-based treatment
therapies for cancer is also boosting the demand for the same. The research and
development in the platinum drug market to enhance the target concentration in
the drug are projected to serve the numerous opportunities in this market
shortly. Furthermore, Different types of platinum-based drugs are available
including carboplatin, cisplatin, oxaliplatin and other. The growing use of
these products in the treatment of various cancers including ovarian, lung,
brain, and others are contributing to the market growth.
Key Challenges faced by platinum-based cancer drug market:
The threat of failure and the adverse effects of
platinum-based drugs, mostly in chemotherapy is expected to hamper the growth
of the cancer drugs market. the platinum-based drugs used in the chemotherapy
have several side effects including Kidney toxicity, Nausea and vomiting, and,
many others. Relative, the carboplatin has fewer side effects as compared to
the other platinum-based cancer drugs.
The Cisplatin may cause diarrhea, temporary hair loss, loss
of inability to taste the food, and dark urine. These effects can commonly
occur in more than 40% of patients that platinum-based drugs. The concern
related to the side effect of platinum-based drugs is restraining the growth of
platinum drug market.
Competitive Landscape
Amgen Inc., Johnson & Johnson, GlaxoSmithKline, Eli
Lilly & Co., Roche Diagnostics, Novartis AG, Pfizer, Merck & Co.,
Sanofi, Celgene corporation are me of the key players in the platinum-based
cancer drug market. the key players hold more than 80% of total market shares
in the platinum-based cancer drug market. These players are relied upon to
principally keep up their key spotlight on organizations and acquisitions with
littler yet dynamic players. Furthermore, the introduction of new and advanced
products in the platinum-based cancer drugs market.
For instance, According to the health authorities, the
platinum-based advanced drugs such as Tecentriq® plus platinum-based
chemotherapy offers a reduction of cancer deaths. These platinum-based cancer
drugs help patients outcomes. Furthermore, the companies are more investing in
the research and development of these Nobel metal-based drugs that projected to
improves their product portfolio and operating margins in the upcoming years.
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/4417209-global-platinum-cancer-drugs-market-segment-analysis-opportunity?utm_medium=Jiten-1.10&utm_source=PR
About Us:
Wise Guy Reports is part of the Wise Guy Research
Consultants Pvt. Ltd. and offers premium progressive statistical surveying,
market research reports, analysis & forecast data for industries and
governments around the globe.
Contact Us:
NORAH
TRENT
Ph:
+162-825-80070 (US)
Ph:
+44 203 500 2763 (UK)
Comments
Post a Comment